Micha Loebermann

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Extracorporeal Membrane Oxygenation

Coronavirus Disease

Immune Response

Top Venues

Nature reviews. Neurology

Neurology(R) neuroimmunology & neuroinflammation

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen, Ralf Tönnies, Reiner Ahrendt, Petra Emmerich
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management. Viruses 16 (1) (2024)
Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen, Ralf Tönnies, Reiner Ahrendt, Petra Emmerich
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management. Viruses 16 (1) (2024)
Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen, Ralf Tönnies, Reiner Ahrendt, Petra Emmerich
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management. Viruses 16 (1) (2024)
Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen, Ralf Tönnies, Reiner Ahrendt, Petra Emmerich
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management. Viruses 16 (1) (2024)
Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen, Ralf Tönnies, Reiner Ahrendt, Petra Emmerich
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management. Viruses 16 (1) (2024)
Alexander Winkelmann, Micha Loebermann, Michael Barnett, Hans-Peter Hartung, Uwe K Zettl
Vaccination and immunotherapies in neuroimmunological diseases. Nature reviews. Neurology 18 (5) (2022)
Alexander Winkelmann, Christoph Metze, Silvius Frimmel, Emil C Reisinger, Uwe K Zettl, Micha Loebermann
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study. Neurology(R) neuroimmunology & neuroinflammation 7 (2) (2020)
Micha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, Esther Heijnen, Daniel Kirby, Emil C Reisinger
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. Infection 47 (1) (2018)
Christoph Metze, Alexander Winkelmann, Micha Loebermann, Michael Hecker, Brunhilde Schweiger, Emil Christian Reisinger, Uwe Klaus Zettl
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies. CNS neuroscience & therapeutics 25 (2) (2018)